The expression of CYP2B6 is altered in liver tissues with fatty degeneration [17], and there have been reports of a link between the expression of Cyp2b10 and the risk of NAFLD in mice [18]. Here, CYP2B6 is linked to metabolic dysfunction-associated steatotic liver disease.